SCHEMBL3922468

SCHEMBL3922468

CC(C)N(CCC(c1ccccc1O)c1cc(Cl)ccc1O)C(C)C

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRM3 P20309 4/20 0.59
▸ LMNA P02545 4/20 0.59
▸ MAPT P10636 4/20 0.59
▸ CHRM2 P08172 2/20 0.59
▸ CHRM5 P08912 2/20 0.59
▸ CHRM1 P11229 2/20 0.59
▸ HRH1 P35367 2/20 0.59
▸ ESR1 P03372 1/20 0.59
▸ CHRM4 P08173 1/20 0.59
▸ KCNE1 P15382 1/20 0.59
▸ PTGS1 P23219 1/20 0.59
▸ HRH2 P25021 1/20 0.59
▸ HTR2A P28223 1/20 0.59
▸ SLC6A4 P31645 1/20 0.59
▸ ADRA1A P35348 1/20 0.59
▸ OPRK1 P41145 1/20 0.59
▸ KCNQ1 P51787 1/20 0.59
▸ KCNH2 Q12809 1/20 0.59
▸ CACNA1C Q13936 1/20 0.59
▸ SCN5A Q14524 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9224718 0.89 CHRM3 (0.74) CHRM3LMNAMAPTCHRM2CHRM5
SCHEMBL4663940 0.89 CHRM3 (0.74) CHRM3LMNAMAPTCHRM2CHRM5
SCHEMBL8858842 0.87 CHRM3 (0.60) CHRM3LMNAMAPTCHRM2CHRM5
Hydrochloric Acid SCHEMBL3928143 0.85 CHRM3 (0.58) CHRM3LMNAMAPTCHRM2CHRM5
SCHEMBL9223163 0.85 CHRM3 (0.80) CHRM3LMNAMAPTCHRM2CHRM5
Cadaverine Tartrate SCHEMBL9110378 0.83 CHRM3 (0.79) CHRM3LMNAMAPTCHRM2CHRM5
Cadaverine Tartrate SCHEMBL9111161 0.83 CHRM3 (0.79) CHRM3LMNAMAPTCHRM2CHRM5
SCHEMBL9221335 0.82 LMNA (0.45) CHRM3LMNAMAPTCHRM2CHRM5
SCHEMBL6939192 0.80 CHRM3 (0.72) CHRM3LMNAMAPTCHRM2CHRM5
SCHEMBL4664069 0.80 CHRM3 (0.72) CHRM3LMNAMAPTCHRM2CHRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE40851-E1 3,3-diphenylpropylamines, their use and preparation PFIZER HEALTH AB (SE) 2009-07-14 — — US disclosed
US-RE39667-E1 3,3-Diphenylpropylamines, their use and preparation PFIZER HEALTH AB (SE) 2007-05-29 — — US disclosed
EP-0667852-B1 NOVEL 3,3-DIPHENYLPROPYLAMINES, THEIR USE AND PREPARATION PHARMACIA & UPJOHN AB (SE) 1998-04-08 — — EP disclosed
US-5686464-A ANTICHOLINERGIC AGENTS; URINARY INCONTINENCE TREATMENT PHARMACIA AB (SE) 1997-11-11 — — US disclosed
US-5559269-A ANTICHOLINERGIC AGENTS PHARMACIA AB (SE) 1996-09-24 — — US disclosed
EP-0667852-A1 NOVEL 3,3-DIPHENYLPROPYLAMINES, THEIR USE AND PREPARATION Pharmacia & Upjohn Aktiebolag (SE) 1995-08-23 — — EP disclosed
WO-1994011337-A9 NOVEL 3,3-DIPHENYLPROPYLAMINES, THEIR USE AND PREPARATION — 1995-07-06 — — WO disclosed
US-5382600-A 3,3-diphenylpropylamines and pharmaceutical compositions thereof PHARMACIA AKTIEBOLAG (SE) 1995-01-17 — — US disclosed
WO-1994011337-A1 NOVEL 3,3-DIPHENYLPROPYLAMINES, THEIR USE AND PREPARATION PHARMACIA AB (SE) 1994-05-26 — — WO disclosed
EP-0325571-B1 NEW AMINES, THEIR USE AND PREPARATION Kabi Pharmacia AB (SE) 1991-08-07 — — EP disclosed
EP-0354234-A1 NEW AMINES, THEIR USE AND PREPARATION KabiVitrum AB (SE) 1990-02-14 — — EP disclosed
WO-1989006644-A1 NEW AMINES, THEIR USE AND PREPARATION KABIVITRUM AB (SE) 1989-07-27 — — WO disclosed
EP-0325571-A1 New amines, their use and preparation Kabi Pharmacia AB (SE) 1989-07-26 — — EP disclosed
Send feedback